PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing (LKS) Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.\', \'Department of Family Medicine and Primary Care, Li Ka Shing (LKS) Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.\', \'Laboratory of Data Discovery for Health Limited, Hong Kong SAR, China.\', \'Division of Endocrinology and Metabolism, Department of Medicine, Li Ka Shing (LKS) Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.\', \'World Health Organization (WHO) Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing (LKS) Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fendo.2022.810914
?:hasPublicationType
?:journal
  • Frontiers in endocrinology
is ?:pmid of
?:pmid
?:pmid
  • 35321338
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.79
?:rankingScore_hIndex
  • 42
?:title
  • Metformin Use in Relation to Clinical Outcomes and Hyperinflammatory Syndrome Among COVID-19 Patients With Type 2 Diabetes: A Propensity Score Analysis of a Territory-Wide Cohort.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35321338>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35321338>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all